ZPDH.DE vs. XGEN.DE
ZPDH.DE (SPDR S&P US Health Care Select Sector UCITS ETF) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds - ZPDH.DE tracks the S&P Health Care Select Sector while XGEN.DE tracks the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, ZPDH.DE returned 3.67%/yr vs 1.39%/yr for XGEN.DE. A 0.61 correlation means they provide meaningful diversification when combined. ZPDH.DE charges 0.15%/yr vs 0.30%/yr for XGEN.DE.
Performance
ZPDH.DE vs. XGEN.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZPDH.DE achieves a -1.12% return, which is significantly higher than XGEN.DE's -1.40% return.
ZPDH.DE
- 1D
- 2.83%
- 1M
- 5.48%
- YTD
- -1.12%
- 6M
- -0.21%
- 1Y
- 13.04%
- 3Y*
- 3.67%
- 5Y*
- 6.73%
- 10Y*
- 8.92%
XGEN.DE
- 1D
- 3.92%
- 1M
- 6.45%
- YTD
- -1.40%
- 6M
- -3.78%
- 1Y
- 22.37%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
ZPDH.DE vs. XGEN.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ZPDH.DE SPDR S&P US Health Care Select Sector UCITS ETF | -1.12% | 1.73% | 8.46% | -1.73% | 1.41% |
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
Correlation
The correlation between ZPDH.DE and XGEN.DE is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.65 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.61 |
The correlation between ZPDH.DE and XGEN.DE has been stable across timeframes, ranging from 0.61 to 0.65 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZPDH.DE vs. XGEN.DE — Risk / Return Rank
ZPDH.DE
XGEN.DE
ZPDH.DE vs. XGEN.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P US Health Care Select Sector UCITS ETF (ZPDH.DE) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ZPDH.DE | XGEN.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.34 | ||
| Sortino ratioReturn per unit of downside risk | -0.43 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.21 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 1.21 | 1.49 | -0.28 |
| Martin ratioReturn relative to average drawdown | 2.95 | 3.61 | -0.66 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ZPDH.DE | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.89 | 1.23 | -0.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.46 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.56 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | -0.11 | +0.56 |
Drawdowns
ZPDH.DE vs. XGEN.DE - Drawdown Comparison
The maximum ZPDH.DE drawdown since its inception was -26.61%, smaller than the maximum XGEN.DE drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for ZPDH.DE and XGEN.DE.
Loading charts...
Drawdown Indicators
| ZPDH.DE | XGEN.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.61% | -37.58% | +10.97% |
Max Drawdown (1Y)Largest decline over 1 year | -10.77% | -14.99% | +4.22% |
Max Drawdown (3Y)Largest decline over 3 years | -22.64% | -28.21% | +5.57% |
Max Drawdown (5Y)Largest decline over 5 years | -22.64% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -26.61% | — | — |
Current DrawdownCurrent decline from peak | -7.28% | -14.86% | +7.58% |
Average DrawdownAverage peak-to-trough decline | -5.80% | -19.44% | +13.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 6.19% | -1.78% |
Volatility
ZPDH.DE vs. XGEN.DE - Volatility Comparison
The current volatility for SPDR S&P US Health Care Select Sector UCITS ETF (ZPDH.DE) is 5.13%, while Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) has a volatility of 6.48%. This indicates that ZPDH.DE experiences smaller price fluctuations and is considered to be less risky than XGEN.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZPDH.DE | XGEN.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.13% | 6.48% | -1.35% |
Volatility (6M)Calculated over the trailing 6-month period | 10.16% | 13.73% | -3.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.63% | 18.19% | -3.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.47% | 18.66% | -4.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.77% | 18.66% | -2.89% |
ZPDH.DE vs. XGEN.DE - Expense Ratio Comparison
ZPDH.DE has a 0.15% expense ratio, which is lower than XGEN.DE's 0.30% expense ratio.
Dividends
ZPDH.DE vs. XGEN.DE - Dividend Comparison
Neither ZPDH.DE nor XGEN.DE has paid dividends to shareholders.
Frequently Asked Questions
ZPDH.DE and XGEN.DE have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, ZPDH.DE is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
ZPDH.DE is cheaper with a 0.15% expense ratio, compared with 0.30% for XGEN.DE.
ZPDH.DE tracks S&P Health Care Select Sector, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. They also come from different issuers: State Street and Xtrackers. Their fees differ too: 0.15% for ZPDH.DE and 0.30% for XGEN.DE.
Find the right allocation for ZPDH.DE and XGEN.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer